Compounds > 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one
Page last updated: 2024-08-26

1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and DDD MPGNII

1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one has been researched along with DDD MPGNII in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hilkin, BM; Lambris, JD; Nester, CM; Ricklin, D; Shao, D; Smith, RJ; Zhang, Y1

Other Studies

1 other study(ies) available for 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and DDD MPGNII

ArticleYear
Compstatin analog Cp40 inhibits complement dysregulation in vitro in C3 glomerulopathy.
    Immunobiology, 2015, Volume: 220, Issue:8

    Topics: Animals; Cattle; Cells, Cultured; Complement C3; Complement C3-C5 Convertases; Complement Pathway, Alternative; Erythrocytes; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Humans; Peptides, Cyclic; Primates; Pyridones; Sheep

2015